NCT04313374View on ClinicalTrials.gov

Integrated Pulmonary Index and Opioid Based Patient Controlled Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

May 1, 2018

Study Completion Date

August 1, 2018

Conditions
Brain Tumors
Interventions
DRUG

Morphine PCA 1 mg

PCA will set to administer a bolus dose of 1 mg morphine on demand with a lockout period of 10 minutes and maximum 20 mg for 4 hours.

DRUG

Morphine PCA 0,5 mg

PCA set to administer a bolus dose of 0.5 mg morphine on demand with a lockout period of 10 minutes and maximum 20 mg for 4 hours.

DRUG

Placebo

the PCA will contain placebo

Trial Locations (1)

34304

Istanbul University Cerrahpasa Medical School, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT04313374 - Integrated Pulmonary Index and Opioid Based Patient Controlled Analgesia | Biotech Hunter | Biotech Hunter